Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRUG
3576
Bright Minds Biosciences
DRUG
$508M
| $229K | ﹤0.01% |
3,256
+179
| +6% | +$14.1K |
|
|
VIA
3577
Via Transportation Inc
VIA
$2.4B
| $228K | ﹤0.01% |
12,590
+8,535
| +210% | +$134K |
|
3578
State Street SPDR S&P Dividend ETF
SDY
$20.7B
| $228K | ﹤0.01% |
1,500
| – | – |
|
3579
JELD-WEN Holding
JELD
$160M
| $228K | ﹤0.01% |
152,026
+51,194
| +51% | +$78.9K |
|
|
KLRA
3580
Kailera Therapeutics
KLRA
$1.45B
| $228K | ﹤0.01% |
+10,331
| New | +$227K |
|
3581
CareDx
CDNA
$3.29B
| $227K | ﹤0.01% |
7,976
-2,826
| -26% | -$61.5K |
|
3582
Star Bulk Carriers
SBLK
$3.43B
| $226K | ﹤0.01% |
9,033
+8,813
| +4,006% | +$228K |
|
|
INV
3583
Innventure Inc
INV
$61.5M
| $225K | ﹤0.01% |
44,374
-17,589
| -28% | -$103K |
|
3584
Entravision Communication
EVC
$684M
| $224K | ﹤0.01% |
17,209
-78,218
| -82% | -$555K |
|
3585
Perion Network
PERI
$338M
| $223K | ﹤0.01% |
22,975
-1,293
| -5% | -$12.3K |
|
3586
Inhibrx
INBX
$1.47B
| $222K | ﹤0.01% |
2,347
+680
| +41% | +$68.1K |
|
|
KREF
3587
KKR Real Estate Finance Trust
KREF
$372M
| $222K | ﹤0.01% |
32,447
-14,668
| -31% | -$97K |
|
3588
B&G Foods
BGS
$252M
| $221K | ﹤0.01% |
55,638
+13,568
| +32% | +$62.9K |
|
3589
Winmark
WINA
$1.06B
| $221K | ﹤0.01% |
523
-65
| -11% | -$25.4K |
|
3590
Ribbon Communications
RBBN
$322M
| $221K | ﹤0.01% |
94,499
-7,334
| -7% | -$19.4K |
|
3591
Sylvamo
SLVM
$1.43B
| $221K | ﹤0.01% |
5,843
-425
| -7% | -$17.2K |
|
3592
Epsilon Energy
EPSN
$180M
| $220K | ﹤0.01% |
40,682
-1,270
| -3% | -$7.53K |
|
3593
Dynagas LNG Partners
DLNG
$130M
| $219K | ﹤0.01% |
64,800
| – | – |
|
|
AAT
3594
American Assets Trust
AAT
$1.33B
| $218K | ﹤0.01% |
8,823
-50,342
| -85% | -$1.1M |
|
3595
PUT
Corcept Therapeutics
CORT
$12.6B
| $217K | ﹤0.01% |
2,500
| – | – |
|
3596
Schneider National
SNDR
$5.48B
| $217K | ﹤0.01% |
5,949
-1,020
| -15% | -$33.3K |
|
3597
American Well
AMWL
$228M
| $217K | ﹤0.01% |
23,777
-270
| -1% | -$2.02K |
|
3598
Bakkt Inc
BKKT
$383M
| $215K | ﹤0.01% |
27,533
+7,695
| +39% | +$68.9K |
|
3599
York Water
YORW
$503M
| $215K | ﹤0.01% |
7,012
-2,542
| -27% | -$76.3K |
|
3600
Oric Pharmaceuticals
ORIC
$1.36B
| $215K | ﹤0.01% |
19,807
+7,378
| +59% | +$66.9K |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.